Nephros Inc
NASDAQ:NEPH
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Nephros Inc
NASDAQ:NEPH
|
US |
|
Qrf NV
XBRU:QRF
|
BE |
|
Aurora Innovation Inc
NASDAQ:AUR
|
US |
|
Alkemy SpA
MIL:ALK
|
IT |
|
Cloudflare Inc
NYSE:NET
|
US |
|
United Overseas Bank Ltd
SGX:U11
|
SG |
|
D
|
DaVita Inc
F:TRL
|
US |
|
Equinor ASA
F:DNQ
|
NO |
|
Deluxe Corp
NYSE:DLX
|
US |
|
E
|
Eli Lilly and Co
SIX:LLY
|
US |
|
American Eagle Outfitters Inc
NYSE:AEO
|
US |
|
W
|
Weyerhaeuser Co
F:WHC
|
US |
|
H
|
Healthcare Trust Of America Inc
F:HT01
|
US |
|
Strongpoint ASA
OSE:STRO
|
NO |
Wall St Price Targets
NEPH Price Targets Summary
Nephros Inc
According to Wall Street analysts, the average 1-year price target for NEPH is 7.14 USD with a low forecast of 6.06 USD and a high forecast of 8.4 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is NEPH's stock price target?
Price Target
7.14
USD
According to Wall Street analysts, the average 1-year price target for NEPH is 7.14 USD with a low forecast of 6.06 USD and a high forecast of 8.4 USD.
What is the Revenue forecast for Nephros Inc?
Projected CAGR
11%
Over the last 14 years, the compound annual growth rate for Revenue has been 17%. The projected CAGR for the next 2 years is 11%.
What is the Operating Income forecast for Nephros Inc?
Projected CAGR
18%
The compound annual growth rate for Operating Income over the next 2 years is 18%.
What is the Net Income forecast for Nephros Inc?
Projected CAGR
9%
The compound annual growth rate for Net Income over the next 2 years is 9%.
